Skip to main content
Get Alerts

Health Alerts

Your unified view of current, active outbreak investigations, elevated disease activity, and food and drug recalls -- reported directly by CDC, FDA, and USDA. Not CDC NORS, which is a historical archive compiled well after an investigation closes (see Data Explorer for the full historical record).

Download matching alerts as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Browse full recall history in Data Explorer →

View all Drug Recalls & FDA announcements →

Filters
Date range
Sort
Recall details
Clear filters

Showing 121–140 of 413 alerts

Drug Recall 2026 record Source: FDA

Rohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0.05%, zinc sulfate 0.25%), Sterile 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam UPC 310742010862, NDC 10742-8146-1

Recall initiated
July 14, 2026
Reported by FDA
July 29, 2026

View Details

Food Recall 2026 record Source: FDA

PT Organics Limited

Recall initiated
July 13, 2026
Reported by FDA
August 12, 2026

View Details

Drug Recall 2026 record Source: FDA

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3563-0; NDC Blister: 0904-6956-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3562-0; NDC Blister: 0904-6951-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3559-0; NDC Blister: 0904-6950-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Carton: 55154-3558-0; NDC Blister: 0904-6949-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6956-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6955-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6954-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6949-61

Recall initiated
July 13, 2026
Reported by FDA
July 29, 2026

View Details

Drug Recall 2026 record Source: FDA

BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTION, CareFusion 123, LLC, El Paso, TX, subsidiary of Beckton, Dickson and Co. NDC 54365-400-31

Recall initiated
July 9, 2026
Reported by FDA
July 22, 2026

View Details

Drug Recall 2026 record Source: FDA

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30

Recall initiated
July 8, 2026
Reported by FDA
July 29, 2026

View Details

Data last updated:

Investigations and recalls may be ongoing; status, case counts, and guidance are updated by the source agency as events continue. Read the full medical disclaimer.

Explore more